IL6 and metabolic disease: In addition, prolonged anhepatic time could increase the risk of graft dysfunction and metabolic disorders, mainly due to the accumulation of cytokines (e.g., interleukin 6), metabolites and other toxicants, and finally deteriorated renal function and reduced patient survival29.